The second season of Research Matters, a Cornell video podcast, drops today, with a way-too-relevant episode on why we don't always do the things we know we should.
Weill Cornell Medicine has received a three-year, $2.5 million grant from the Department of Defense to develop therapies with fewer side effects for triple-negative breast cancer, one of the most aggressive and difficult-to-treat breast cancers.
Researchers have uncovered how a key Parkinson’s protein shifts between inactive and active forms, revealing the structural changes that enable certain mutations to push the protein into an overactive state.
Weill Cornell Medicine anesthesiologist Dr. Gunisha Kaur has been appointed to the U.S. Commission on International Religious Freedom, an agency that monitors the universal right to freedom of religion or belief.
An NSAID-related compound called ampyrone appears to safely boost production of the pigment melanin in human skin, according to a preclinical study led by Weill Cornell Medicine and National Eye Institute investigators.
A new way to measure comorbidity can be used to accurately predict a patient’s risk of hospitalization and future healthcare costs across a population.
The protein makes blood vessels leakier to allow metastatic tumors to form in the lungs, according to a study led by investigators at Weill Cornell Medicine and Memorial Sloan Kettering Cancer Center.
Researchers have identified a site where a commonly used anesthetic binds to sodium ion channels, revealing a molecular mechanism that may explain how these drugs dampen communication between neurons.
Andrew Flyak, assistant professor in the Department of Microbiology and Immunology in the College of Veterinary Medicine, has been named a 2026 Pew Scholar in the Biomedical Sciences.